Written by our clinical people, for our clinical people
Edition nine Summer - autumn 2024
Welcome
We are pleased to share the ninth edition of Our Journal
Our Journal includes the below, with reference to the articles in this edition:
y Awards/clinical recognition: divisional director appointed to prestigious national role; Medical Education Annual Thank You and Awards Celebration; latest DAISY awards winner announced; dedicated nurses recognised for prestigious awards programme
y Conference and event reviews/updates: medical education team share the latest updates
y Clinical leadership successes: welcoming our new co-chairs of the Resident Doctors' Committee; emergency department introduce shared governance council
y PAHT 2030
y Research updates: latest research at PAHT highlights our focus on transforming our care
y Quality and safety agenda: Painkillers don't exist: opioids awareness
y Clinical transformation updates
y Focus features on clinical issues/improvements and the impact on patient care
y Input from external contributors
y Summary of research contributions and papers published by PAHT clinicians
Our Journal provides an amazing opportunity for us to showcase the wonderful work we do – please share it widely and let the communications team know which developments we can profile in the next edition of Our Journal at paht.communications@nhs.net
Best wishes
Dr Fay Gilder Medical director
Sharon McNally Interim chief executive
Dr Fay Gilder
Sharon McNally
Divisional director appointed to prestigious national role
By Dr Monica Bose, divisional director for clinical support services and consultant gastroenterologist
I am proud to have been appointed to a prestigious role with the British Society of Gastroenterology (BSG).
I have been appointed as the national deputy chair and quality improvement lead for the clinical services and standards committee (CSSC) of the BSG.
This follows me holding the role of the chair of the BSG clinical services and standards committee in the East of England for several years previously.
I am passionate about supporting service development and quality improvement in gastroenterology.
It is a great honour to be appointed to this national role. It gives me the opportunity to contribute to the national conversation around improving care for patients in gastroenterology.
I hope to support colleagues in developing and embedding innovative and transformative approaches to service delivery and sharing best practice.
For more information, please contact me at monicabose@ nhs.net
Medical Education Annual Thank You and Awards Celebration
Well done to our medical staff who were recognised in the Medical Education Annual Thank you and Awards Celebration.
The annual event, held at the Harlow Rugby and Football Club on 4 July 2024, was fantastically attended and a great evening was had by all. The event aims to recognise and thank our medical staff for all their hard work and celebrate their achievements, improvement and education throughout the year.
There were six categories for judging as follows:
Outstanding Contribution, Clinical Excellence, Junior Teaching, E-portfolio, Quality Improvement and Leadership.
Congratulations to the junior medical staff nominated: Zara Al-Faham, Eyad Ali, Doreena Arokianathar, Maximillian Carstensen, Daniel Crossman, Rasanga Wijesinha, Doyinsola Dada, Hazel Harry, Rebecca Howard, Harry Hudson, Galal Imtiaz, Mina Al Janabi, Mohammed Sa’ud Jiwani, Salih Kadri, Gita Lingam, Narek Sargsyan, Mohamed El Sawaf, Gabrielle Sanders, Anita Stowell, Maariya Tariq, Zaneta Valinciute, Kieron Young.
Outstanding Contribution Award
y Winner: Dr Narek Sargsyan
y Runner up and highly commended: Dr Zaneta Vinciute
Clinical Excellence Award
y Winner: Dr Doyinnsola Dada
y Runners up and highly commended: Hazel Harry, Dr Kieron Young, Dr Vidhya Charavanamuttu
Junior Teaching Award
y Winner: Dr Maariya Tariq
y Runners up and highly commended: Dr Mohammed Sa’ud Jiwani, Dr Bhagyashree Patel
E-portfolio
y Winner: Rebecca Howard won e-portfolio
y Runner up and highly commended: Dr Doreena Arokianathar
Quality Improvement Award
y Winner: Dr Maximilian Carstensen
Leadership Award
y Winner: Dr Rasanga Wijesinha and Dr Daniel Crossman
Mr Kar Teoh Memorial Award 2024 for outstanding contribution to undergraduate medical education
y Awarded to: Dr Teifion Davies
Educator Award
There were twenty nominees for the educator award as follows: Dr Ehab Abdelmalek, Dr Ziena Abdullah, Dr Iman Almabhooh, Dr Hersh Basra, Dr Vidhya Charavanan, Dr Rasim Chowdhury, Dr Jeevan Gopal, Dr Nabila Iram, Dr Naveed Kirmani, Dr Ayesha Lal, Mr
Jehangir Mahaluxmival, Dr Anna McCorquodale, Dr Haider Mosea, Mr Dimitrios Panagos, Dr Nicola Ray, Dr Dayasagar Reddivari, Dr Boris Rosenberg, Dr Kellie Stevens.
Medical Education 2024 Educator Award
y Winner of the Consultant
Trauma and Orthopaedic Surgeon 2024: Mr Jehangir Mahaluxmivala
y Runners up and highly commended: Dr Dimitrios Panagos, Dr Ahmed Sarhan and Dr Dennis Kosuge
For more information, please contact judith.butcher@nhs. net
Welcoming our new co-chairs of the Resident Doctors' Committee
The medical education team are pleased to welcome to Dr Pavit Tewatia and Dr Hesham Metwally as the new co-chairs of the Resident Doctors' Committee.
Dr Hesham Metwally, speciality registrar (SpR), elderly care medicine
Hesham is a medical registrar who usually works on Winter Ward at The Princess Alexandra Hospital and has been in the NHS for the last two years. Outside of work, he enjoys training, travelling, and reading.
You can contact Hesham at hesham.metwally@nhs.net for topics related to junior doctors.
Dr Pavit Tewatia, speciality registrar (SpR), gastroenterology
Pavit is a dedicated internal medicine physician with a specialist interest in gastroenterology. He is passionate about collaboration, teamwork, and patient-centred healthcare. Outside of work, he enjoys travelling, cooking, surfing, and playing the guitar.
You can contact Pavit at pavit.tewatia@nhs.net for topics related to junior doctors.
Painkillers don't exist: opioid awareness
By Steven De-Giovanni, medication safety officer and deputy chief pharmacist
Opioids, such as codeine, morphine, oxycodone and tramadol can provide highly effective pain relief when used in the short-term. However, when used over longer periods they can lead to dependence, cause physical and mental health issues, or even death from accidental overdoses or heart conditions resulting from side effects.
This risk is further increased for patients on high strength opioids (those on greater than 120mg of morphine or an equivalent a day). Other medication, such as pregabalin, gabapentin, benzodiazepines and medicines used in anxiety and depression can have an addictive effect and further increase such a risk.
Despite these health risks, long-term opioid use is common, with data from January 2021 showing that over 1 million people in England were prescribed opioids for more than three months. Within Herts and West Essex, clinicians are committed to reducing the number of patients who are unnecessarily on high-strength
opioids for greater than three months. This will lead to an improvement in patient wellbeing, patient experience and less side-effects. Tapering or stopping high dose opioids requires careful planning and collaboration with the patient and all members of their healthcare team. Tapering from a high dose may take weeks or months, and requires a strong relationship between the prescriber and patient, where the benefits are fully understood.
What can we do at PAHT?
Although the prescribing of opioids in chronic pain is led in primary care, staff at PAHT can make every contact count. This includes:
1. Identify: Is the patient on high dose prescription opioids (≥ 120mg oral morphine equivalent over 24 hours) for longer than three months? (Exclude palliative care or cancer). This can be done through prescribing reporting via pharmacy.
2. Note: Note high dose unlikely to be beneficial and may cause harm.
3. Inform: Inform the patient of risks and adverse effects with long term opioids.
4. Discuss: Discuss with the patient around willingness for gradual dose reduction.
5. Signpost: If willing, ask them to contact their GP practice for reduction support and signpost to useful information: flippinpain.co.uk, or livewellwithpain.co.uk.
6. Communicate: Let the GP practice know the patient is open to reducing their opioid doses over time.
This is a project across the Hertfordshire and West Essex Integrated Care System, with more information here >
You can also contact me at steven.de-giovanni1@ nhs.net.
Medical education team share the latest updates
Our medical education team has hosted a wide range of events since the last edition of Our Journal. These have included:
y We held our annual Medical Education Thank You and Awards Celebration on 4 July
y We introduced our new Undergraduate Medical Education Programme update half day on 17 September, held in the Learning and Education Centre
y We hosted the Physician Associate Regional Stakeholder Event on 25 September at the Radisson Blu Hotel Stansted. This was a great opportunity for our stakeholders and physician associates to network and share best practice
y We held a Masterclass in Clinical Leadership for staff and associate specialist (SAS) doctors on 4 October
y We held a Portfolio Pathway (CESR) Session for Supervisors and Mentors on 14 October
y We hosted a GPST Away Day Trainee Workshop and Team Building event at Down Hall on 15 October
y We hosted a Bowel Anastomosis Workshop for Core Surgical Trainees and ST3 East of England Trainees, on 18 October, 12.30pm-4pm
y We held an Orientation to Clinical Practice on 21 October, from 9am-4pm. A full day’s session was arranged for our new International Medical Graduates (IMGs), Locally Employed Doctors (LEDs) and returners to work (following maternity leave, prolonged period of absence etc.)
Upcoming events include:
y Masterclass in Clinical Leadership for SAS Doctors, 1 November, from 9am-4pm. Please note that this event is fully booked
y Clinical Supervisor Tier 2 training, 5 November, 9am-12pm. If you are interested in attending, please contact margaret.short@nhs.net
y Foundation Training Programme Update, 15 November, from 12.30pm-3.30pm. Dr Nik Cholidis, foundation programme director, will deliver the next of his popular update sessions. We strongly recommend this update session for all our new educators. To book, please email margaret.short@nhs.net
y Sexual Safety, Bullying and Harassment Workshop, 29 November, 9.30am – 12.30pm (morning) and 1.30pm-4.30pm (afternoon). On 4 September, NHS England launched its first ever Sexual Safety Charter in collaboration with key partners across the healthcare system. PAHT signed up to the charter, which commits to taking and enforcing a zerotolerance approach to any unwanted behaviour, inappropriate and/or harmful sexual behaviours within the workplace, and to ten core principles and actions to help achieve this. This short course is aimed at raising awareness of sexual safety in the workplace and all clinicians who supervise trainees or medical students are encouraged to attend. If you would like to attend, please contact margaret.short@nhs.net
y Breaking Bad News Workshop, 2 December, 9am-12pm (morning) or 1pm-4pm (afternoon). To book, please email judith.butcher@nhs.net
y Educator Hub Day, 10 December, from 9am-4.30pm. To book, please contact margaret. short@nhs.net
Thank you to everyone involved. For more information, please contact margaret.short@nhs. net and judith.butcher@nhs.net.
Latest DAISY Award winner announced
By Giuseppe Labriola, interim chief nurse
Congratulations to Angela Gatland, a midwife on the maternity unit, who is our latest DAISY Awards® programme winner (for July 2024).
The programme enables patients, families and colleagues to honour a nurse or midwife who has made a difference to their care. The aim is to shine the spotlight on nurses and midwives who go the extra mile to ensure patients at PAHT receive high quality care and experiences.
Angela received two nominations in recognition of the care and compassion shown to women and birthing people, and for going above and beyond to help support the wider family too.
One nomination concluded: “We cannot thank Angela enough for everything she did to help us as a family, but most importantly my daughter.” The other ended: “Angela will be someone who I will always remember and hold close to my heart.”
Jo Ward, interim deputy chief nurse and I surprised Angela when she was at work on 11 September and presented her with her DAISY Award® certificate, a beautiful hand carved Healer’s Touch Sculpture from Zimbabwe,
a pin badge, copy of the full nomination, a gift bag and cinnamon rolls.
I would like to say a very big thank you and congratulations to Angela. The nominations she received are just a glimpse of the care and dedication she shows to women and birthing people and their wider family, putting them at the heart of all she does.
DAISY Award® winners are also entitled to numerous professional development, education and wellness benefits.
For further information, including how to nominate a colleague, visit AlexNet here >
Pictured: From left to right, Jo Ward, interim deputy chief nurse; Angela Gatland, midwife; and Giuseppe Labriola, interim chief nurse.
Emergency department introduce shared governance council
Well done to our emergency department team who have successfully introduced the shared governance council at PAHT in order to ensure that agreements are made in an inclusive and collaborative way, driving forward quality and service improvements, supporting innovation and delivering better outcomes that will benefit our patients and people.
The council (pictured) has already achieved their first significant milestone by introducing a quality improvement project to standardise the process for the glucose monitoring machine calibration; the outcomes will be measured and reviewed in a few months' time.
Shared governance councils are an integral part of the nursing, midwifery and allied
health professionals (AHPs) strategy >
For more information, visit the
dedicated shared governance AlexNet workspace >
Latest research taking place at PAHT highlights our focus on transforming our care
By Nikki White, lead research nurse
We are taking part in a variety of important research studies highlighting our focus on transforming our care at PAHT.
The studies include developments for the care of patients with breast cancer, long-term conditions, chronic obstructive pulmonary disease (COPD) and other lung conditions, and hearing loss.
Please take a look at the latest updates below:
Four Light Study
Principle investigator: Dr Konstantis.
Position nationally: We are 1 of 13 sites in the UK selected to take part in this study.
Overview: A phase 3 study comparing a new drug compound in combination
with Fulvestrant in people with HR-positive, HER2 negative Advanced or Metastatic Breast Cancer who have progressed after a prior line of treatment.
Highlight: Approval for this study to open at PAHT was issued by the RD&I department in August and will be offered to all our patients who fulfil the eligibility criteria to participate.
Purpose and benefits: The purpose of the study is to compare the effects of the investigational drug in combination with Fulvestrant, with comparison drugs that are currently approved for the treatment of this type of breast cancer. The benefits for participants who take part may help future patients with this type of breast cancer by increasing the understanding of using the study drug and also improve their condition and health, however there is no guarantee that participants will receive any benefit.
Significance: The aim of the study is to determine that using the study drug alongside Fulvestrant improves survival rates and less side effects.
Progress so far: We are actively looking for eligible patients and are hoping to recruit our first patient in the next few weeks. The first patient was recruited in the UK in August.
Admissions Study
Principle Investigator: Janice Bernardo.
Overview: The aim of this study is to improve the
understanding of how NHS staff make decisions regarding patients with multiple long-term conditions. NHS staff involved with the decision-making for these patients are invited to take part in an interview.
Highlight: Approval for this study to open at PAHT was issued by the research, development and innovation (RDI) department in July.
To date, four members of staff have agreed to participate. We have a minimum target of six participants to recruit.
Purpose and benefits: The purpose of the study is to gain a better understanding of current clinical practice of how this group of patients are managed and the potential challenges NHS staff face when making decisions around the clinical care of these patients.
Significance: The study aims to lay foundations for new approaches to the recognition and treatment of multimorbidity in hospital and inform the design of future care, with potential to improve healthcare outcomes for the millions of patients with multimorbidity admitted to hospital each year.
Progress so far: Staff working in the emergency depatment (ED), acute assessment areas and Frailty Unit have been invited to take part.
OPACE
Principle Investigator: Dr Anwar.
Overview: This study is
recruiting patients who are known to have chronic obstructive pulmonary disease (COPD) and taking azithromycin on a long-term basis.The aim of the study is to determine whether patients should be advised to continue or stop taking their medication once their COPD has become more stable or whether to advise them to stop it over the summer months when fewer flare-ups tend to occur.
Highlight: Approval for this study to open at PAHT was issued by the research, development and innovation department in August and the first patient was successfully recruited in September.
Purpose and benefits: It is currently unknown whether doctors should advise patients to continue or stop taking azithromycin once their COPD has become more stable, or to advise them to stop taking it over the summer months when fewer flare-ups are likely to occur. It is also not known if azithromycin is more effective in some people or more likely to cause side effects in others. Therefore the purpose of the trial is to answer these questions to find out how best to use azithromycin in managing COPD.
Participating patients may not receive any benefits, as they will not know whether they are receiving azithromycin all the time or not, although they may experience fewer side effects. The long-term benefits of the trial will help patients with COPD in the future as the study will determine how best to use azithromycin long-
term for patients with COPD.
Significance: The trial aims to answer the questions already outlined and is measured on the time to first exacerbation of COPD since starting trial medication.
Progress so far: To date we have not received any updates from the study sponsor. At PAHT, the first patient was recruited in September.
SBIVA
Principle Investigator: Dr Anwar.
Overview: This study is investigating whether 7 or 14 days of intravenous (IV) antibiotic treatment for patients experiencing a flare-up of their bronchiectasis is best.
Highlight: Approval for this study to open at PAHT was issued by the research, development and innovation department in June and the first patient was successfully recruited in July.
Purpose and benefits: Bronchiectasis affects around 300,000 people in the UK. International guidelines recommend that patients receive intravenous antibiotics for 14 days if they are particularly unwell, have an infection with resistant organisms, or if oral antibiotics are ineffective. The duration is based on expert advice but there have not been any studies confirming what length of course is best. There is some evidence to suggest that patients receiving seven days of intravenous antibiotics took
longer to next exacerbation (flare up) compared to those receiving treatment for 14 days. Treating for too long may keep people in hospital longer than needed or increase their risk of antibiotic side effects, whereas treating for too short a period may increase the risk of an infection soon after completion of antibiotic therapy. This study is investigating whether seven or 14 days of intravenous antibiotics is best for patients experiencing a flare up of their bronchiectasis.
Significance: The study is measuring the duration of time (up to one year) between starting intravenous antibiotics until needing another course of either oral or intravenous antibiotics for an exacerbation of bronchiectasis in each group to see which is shorter. The benefits of taking part may help to improve bronchiectasis treatment and healthcare in the future. It is anticipated that the study confirms that a shorter seven day treatment period is better than 14 days, this will be less burdensome and will reduce the risk of developing antibiotic resistance and experiencing fewer or shorter lived side effects.
Progress so far: The first patient was recruited in July, to date we have recruited 4 with a target of 10 to reach by August 2026. To date, we have not received any overall study updates from the Sponsor.
STARFISH
Principle Investigator: Miss Kiverniti.
Overview: This study is investigating the best administration route of steroid treatment in patients who experience idiopathic sudden sensorineural hearing loss.
Highlight: Approval for this study to open at PAHT was issued by the research, development and innovation department in January and has proved to be quite difficult to recruit into, however we successfully recruited our first patient in August.
Purpose and benefits: It is known the treatment for sudden onset of hearing loss is steroids; this study aims to find out through which route of steroid treatment works best in improving hearing for patients with this type of hearing loss.
Significance: Two main aims: to understand which treatment leads to the best recovery of hearing, measured by hearing test results and the impact of the hearing loss on dayto-day life and to improve the early detection and treatment of idiopathic sudden sensorineural hearing loss (ISSNHL).
Progress so far: PAHT is 1 of 42 sites open in the UK. To date, we have screened 6 patients and recruited 1.
NIMBLE
Principle Investigator: Dr Russell.
Overview: This study is looking at patients who have CT scans for lung changes and providing a blood sample which looks at markers
circulating in the blood that can detect cancer earlier.
Highlight: This study closed to recruitment nationally on 01/10/24. PAHT has been recruiting into this study since June 2022 and has recruited a fantastic 30 participants.
Purpose and benefits: The aim of the study is develop a blood test that will improve accuracy of lung nodule follow up and to find the earliest
signs of lung diseases so that treatments work better whist helping to reduce the need for patients to have scans of normal lungs.
Significance: The knowledge and information gained will benefit patients in the future and lead to the development of a blood test to identify these nodules instead of patients having to undergo CT scans.
Progress so far: All patients
attending for a follow up CT scan of their lungs which had previously confirmed a nodule were invited to take part. Patients are then followed up at their next annual routine CT scan until the nodule is confirmed as benign or for 2 years, whichever comes first.
Thank you to all involved.
For more information, please contact me at nikki.white6@ nhs.net
Dedicated nurses recognised for prestigious awards programme
By Giuseppe Labriola, interim chief nurse
A huge congratulations to Charlotte Collings, recruitment and retention nurse, and Kristle Bravo, international nurse educator and manager, who have been shortlisted in the Nursing Times Workforce Summit and Awards 2024
The summit and awards aim to shine a light on those excelling in nurse recruitment and retention, wellbeing and inclusion, plus many other areas linked to helping overcome the ongoing workforce challenge in health and social care.
Charlotte Collings, recruitment and retention nurse (pictured, top, centre), has been shortlisted under the Diversity and Inclusion Champion of the Year category, an important award that recognises people
who have made a significant improvement and continued commitment to championing equality, diversity and inclusion.
Charlotte said: “I was so proud to see my name on the awards shortlist for Diversity and Inclusion Champion of the Year – it came as a real shock.
“My role focuses on successfully recruiting nurses into the organisation and to support them as they join the hospital, settle into their role and beyond.
“Equality, diversity and inclusion is key to ensuring
our people feel valued and respected, regardless of background, age, disability, gender or sexual orientation and I actively strive to ensure equal access to opportunities and progression for all at PAHT.”
Kristle Bravo, international nurse educator and manager (pictured, top right), has been shortlisted under the Practice Educator of the Year category, which aims to recognise exemplary practice educators who go out of their way to provide clinical training, support and development for nurses.
Kristle said: “I am humbled beyond words and deeply honoured to be named as a finalist for Practice Educator of the Year.
“Within my role, I have the privilege of supporting internationally educated nurses as they transition into their new roles at PAHT.
"My focus is to provide them with a strong foundation and the fundamentals of clinical practice to ensure that they are fully equipped to deliver safe and high-quality patient care.
“Transitioning into a new healthcare system can be
challenging, but through structured training, pastoral care, and continuous support, the nurses are able to integrate smoothly into the organisation and succeed in their careers.
“I am dedicated to helping our nurses feel welcomed, confident, and prepared for every aspect of their work and feel very grateful to be recognised for my contributions to this important area of nursing education.”
I’m delighted that both Charlotte and Kristle have been recognised through this prestigious awards scheme.
This is testament to their hard work and exemplary practice, which is valued widely across the organisation, and supports the delivery of our wider nursing, midwifery and allied health professional (AHP) strategy.
Charlotte and Kristle are shining examples of how truly living our values, patient at heart, everyday excellence and creative collaboration, can make a real difference for our people, which ultimately provides better care and experiences for our patients. Thank you to Charlotte and Kristle and the best of luck for the finals on 28 November
Articles and publications - our
#PAHTPeople...
Take a look at some examples of the range of articles published and publications contributed to by our people since the last edition of Our Journal - a fantastic achievement. Full information of authors and articles are available from the library team: paht.lib.desk@nhs.net
y Al-Jabri, T. et al. (2023, "‘Hip Resurfacing Arthroplasty: Past, Present and Future", Orthopaedic Reviews, 15, p. 77745.
y Bahrami, M. et al. (2024), "Association of mammographic and sonographic findings with prognostic molecular factors and hormone receptor expression in malignant breast lesions", Journal of Research in Medical Sciences, 29, pp. 1–7.
y Boyce, L., 2024, "765 Enhancing the Quality of Referrals to Vascular Surgery at a District
General Hospital: A Closed-Loop Quality Improvement Project", British Journal of Surgery, 111(Supplement_6).
y Carstensen, M., 2024, "6201 Updating our approach to clinical communication: evaluation of in situ digital innovation facilitating routine and emergency clinical communication", Archives of Disease in Childhood, 109(Suppl 1), pp.A376-A376.
y Cheng, A., Frank, S., Baines, K., Nathan, M., Douglas, R.V., Sylva, R., Ball, J., Savva, C., Talbot, T., Oikonomidou, O. and Smith, J., 2024, "Real world
experience of trastuzumab deruxtecan for the treatment of metastatic breast cancer in the UK", Journal of Clinical Oncology, 42(16 Supplement), no pagination.
y Clarke, L. and Lockwood, P. (2024), "Student radiographers’ knowledge and experience of lateral hip X-ray positioning: A survey", Radiography (London, England : 1995) [Preprint].
y Daoulah, A., Elmahrouk, A., Arafat, A.A., Alzahrani, B., Alshehri, M., Qenawi, W., Elganady, A., Almahmeed, W., Jamjoom, A., Elmahrouk, Y. and Qutub, M.A., 2024,
"Impact of preoperative intra-aortic balloon pump on outcomes in coronary artery bypass grafting for unprotected left-main coronary artery disease", Cardiovascular diagnosis and therapy, 14(3), p.340.
y Harry, H., Lingam, G. and Kirmani, N., 2024, "820 Antibiotics Because We’re Inserting a Mesh”: A Study to Evaluate Antibiotic Prophylaxis in Elective Hernia Repairs", British Journal of Surgery, 111(Supplement_6).
y Hobor, S., Al Bakir, M., Hiley, C.T., Skrzypski, M., Frankell, A.M., Bakker, B., Watkins, T.B., Markovets, A., Dry, J.R., Brown, A.P. and van der Aart, J., 2024, "Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling", Nature Communications, 15(1), p.4871.
y Kayyale, A.A., Ghani, S. and Olaniyan, O. (2024) "Alvimopan for postoperative ileus following abdominal surgery: a systematic review", Langenbeck’s archives of surgery, 409(1), p. 278.
y Kutty, S. and Mullis, B.H. (2024) "The 2023 Austrian-Swiss-German Fellowship", The Journal of Bone and Joint Surgery, American volume, 106(12), pp. 1130–1135.
y Liew, F. et al. (2024) "Large-scale phenotyping of patients with long COVID posthospitalization reveals mechanistic subtypes of disease", Nature
immunology, 25(4), pp. 607–621.
y Love, S., Mount, A., Kinch, L., Kugan, S., Vora, A. and Davies, T., 2024, "Quality improvement project aiming to reduce inappropriate use of AXRs in the ED", Emergency Medicine Journal.
y Marti Marti, F.E. et al. (2024) "102P Real-world data on overall and progressionfree survival for patients (pts) with metastatic colorectal cancer (mCRC) for the United Kingdom (UK) cohort of the PROMETCO study (PROMETCO-UK)", Annals of oncology, 35, p. S48.
y Powell, A. et al. (2024), "Improved Risk Prediction in Human PapillomavirusAssociated Endocervical Adenocarcinoma Through Assessment of Binary Silva Patternbased Classification: An International Multicenter Retrospective Observational Study Led by the International Society of Gynecological Pathologists (ISGyP)", International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists, 43(5), pp. 436–446.
y Rao, H.J., Iqbal, M.S., Iyer, C., Khalid, A. and Raina, S., 2024, "6007 24 hours ECG in children referred for Holter tape, retrospective study and service evaluation project at Princess Alexandra Hospital, Harlow", Archives of Disease in Childhood, 109(Suppl 1), pp.A95-A96.
y Robert E. Hynds et al.
(2024), "Representation of genomic intratumor heterogeneity in multiregion non-small cell lung cancer patient-derived xenograft models", Nature Communications, 15(1), pp. 1–21.
y Shetty, V. et al. (2022), "Covid-19 and orthopaedic trauma: Quantification of orthopaedic trauma workload and staff resource allocation during a global pandemic-related lockdown", Journal of Clinical Orthopaedics and Trauma, 32.
y Smith, M. et al. (2024) "Dedicated anticoagulation management protocols in fragility femoral fracture care – a source of significant variance and limited effectiveness in improving time to surgery: The hip and femoral fracture anticoagulation surgical timing evaluation (HASTE) study", Injury, 55(8).
y Stevens, J., Rasheed, A., Li, T., Walder, E., Sanwo, O. and Salam, H., 2024, "6394 Mind the youths: integrating mental health into low fidelity simulation for paediatric trainees", Archives of Disease in Childhood, 109(Suppl 1), pp.A327.
y Straw, I., Kirkby, C., and Gopinath, P., 2024, "Connected to the cloud at time of death: a case report", Journal of Medical Case Reports, 18(1), pp. 1–9.
y Walder, E., Stevens, J., Rasheed, A., Li, T. and Salam, H., 2024,
"6809 Keep calm and communicate - integrating simulated communication scenarios to improve confidence of paediatric trainees entering registrar
roles", Archives of Disease in Childhood, 109(Suppl 1), pp.A340-A341.
y Wu, F., Dhir, R. and Ng, C.Y. (2022) "Patterns of Nerve Injury and Recovery Rates of Infraclavicular Brachial Plexus Lesions Following Anterior Shoulder Dislocation", Journal of Hand Surgery, 47(12), p.1227.
Showcase your work in the next edition of Our Journal
Thank you to everyone who has taken part in the first nine editions of Our Journal. It has been excellent to showcase your work, with a broad range of articles. Please contact us at paht.communications@nhs.net to feature in the next edition - publishing in January 2025.
